PTEN and breast carcinoma: One study examined the genomic mutational landscape of over 3000 metastatic breast cancers and noted the most frequent mutations occurred in PIK3CA, FGFR1, and PTEN; however, there was no difference in mutational status between ICI responders and non-responders [30].